Lorenz Mayr
Basel, Basel, Schweiz
22.220 Follower:innen
500+ Kontakte
Info
- Drug Discovery (Preclinical & Early Clinical)
- R&D Management…
Aktivitäten
-
The first time I stood in front of MD Anderson Cancer Center was when my mother was diagnosed with cancer. Now, I am honored to represent ARTIDIS in…
The first time I stood in front of MD Anderson Cancer Center was when my mother was diagnosed with cancer. Now, I am honored to represent ARTIDIS in…
Beliebt bei Lorenz Mayr
-
9 FREE AI Courses. That could change your life... Coursera's AI for Everyone: (Coursera) ↳You’ll learn What is AI?, Building AI Projects, Building…
9 FREE AI Courses. That could change your life... Coursera's AI for Everyone: (Coursera) ↳You’ll learn What is AI?, Building AI Projects, Building…
Beliebt bei Lorenz Mayr
-
Epigenetic editing in neurodegeneration: A recent publication in Science describes the development of CHARM, a compact epigenetic silencer for…
Epigenetic editing in neurodegeneration: A recent publication in Science describes the development of CHARM, a compact epigenetic silencer for…
Geteilt von Lorenz Mayr
Berufserfahrung und Ausbildung
Sprachen
-
English
Verhandlungssicher
-
German
Muttersprache oder zweisprachig
Weitere Aktivitäten von Lorenz Mayr
-
Enjoyed the conversation very much! Thank you Nina for your work to tell the broader audience about initiatives to promote Healthy Aging.
Enjoyed the conversation very much! Thank you Nina for your work to tell the broader audience about initiatives to promote Healthy Aging.
Beliebt bei Lorenz Mayr
-
Infections are major cause of non-relapse death after CAR-T cell therapy: A comprehensive meta-analysis of CAR-T cell therapy studies found that just…
Infections are major cause of non-relapse death after CAR-T cell therapy: A comprehensive meta-analysis of CAR-T cell therapy studies found that just…
Geteilt von Lorenz Mayr
-
Artificial blood – hemoglobin-based oxygen carriers (HBOCs): Availability of articificial blood would avoid temporal or permanent shortage of blood…
Artificial blood – hemoglobin-based oxygen carriers (HBOCs): Availability of articificial blood would avoid temporal or permanent shortage of blood…
Geteilt von Lorenz Mayr
-
Lymphocytes as a living drug for cancer: The FDA approval of lifileucel hallmarks the availability of the first cellular therapy for solid cancer…
Lymphocytes as a living drug for cancer: The FDA approval of lifileucel hallmarks the availability of the first cellular therapy for solid cancer…
Geteilt von Lorenz Mayr
-
Looking forward to discuss the future of antibody development with my distinguished colleagues Taruna Arora, PhD Tomoyuki Igawa and Hironori…
Looking forward to discuss the future of antibody development with my distinguished colleagues Taruna Arora, PhD Tomoyuki Igawa and Hironori…
Beliebt bei Lorenz Mayr
Weitere ähnliche Profile
-
Amir Taheri-Ghahfarokhi
Vernetzen -
Spencer Knight
Vernetzen -
Kenneth Chien
Vernetzen -
Matthias Bozza
Vernetzen -
Khaldoun Alromaih, Ph.D.
Science Executive Director at Hevolution Foundation
Vernetzen -
Mehmood Khan
Vernetzen -
John Gordon
Vernetzen -
May Guo
Vernetzen -
Branko Simic
Vernetzen -
Vishal Gulati
Vernetzen
Weitere Mitglieder, die Lorenz Mayr heißen
-
Lorenz Mayr
Product Engineer für Automotive MOSFETs
-
Lorenz Mayr
MAYR Kanzlei für Arbeitsrecht
-
Lorenz Mayr
-
Lorenz MAYR
Es gibt auf LinkedIn 9 weitere Personen, die Lorenz Mayr heißen.
Weitere Mitglieder anzeigen, die Lorenz Mayr heißen